Quest's $344M Celera Buy Averts Antitrust Hurdle
By Pete Brush ( April 13, 2011, 3:21 PM EDT) -- Quest Diagnostics Inc.'s planned $344 million purchase of genetic research and development company Celera Corp. took a step toward completion Wednesday with the expiration of a statutory waiting period for antitrust regulators to scrutinize the deal....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.